. Distribution Cost Distribution cost in the 1st quarter year 2019 increased compare to the same period last year due to an increase in sales volume that mentioned above. The Company incurred distribution cost THB
. Distribution Cost and Proceed to fund The Company incurred distribution cost and proceed to fund at THB 497 million compare to THB 374 million previous year. An increase mainly came from proceed to fund, since
cost For the 3 months period (quarter 2/2018), the Company has distribution cost at Baht 5.68 million which increased compared to the same quarter of prior year by Baht 2.80 million or equivalent to
person under the Social Security Scheme from one of the subsidiaries to the Company. Distribution costs and selling & administrative expenses increased in the amount of Baht 16.8 million or 10.3%. On the
from distribution fee from outsourced service provider of warehouse management and goods distribution that the company started using since September 2018 which is a total cost of 10.84 million baht
considered appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The Company agreed to waive the rights to purchase the
newspaper production, and termination of newspaper printing at the Company’s Printing and Distribution Center. In addition, the Company would like to clarify the operating results, which loss decreased from
COMPANY LIMITED BIO POWER PLANT COMPANY LIMITED BIO SCIENCE ANIMAL HEALTH PUBLIC COMPANY LIMITED BIRLA CARBON (THAILAND) PUBLIC COMPANY LIMITED BJC C DISTRIBUTION COMPANY LIMITED BJC COFFEE HOLDINGS COMPANY
million and Baht 6.45 million, respectively. Distribution cost For the 3 months period (quarter 3/2018), the Company has distribution cost at Baht 5 .9 7 million which decreased compared to the same quarter
sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the